{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
MDA
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Live Events
  • Online Courses
  • RSS
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numerical character
  • Must contain at least 1 special character


  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

A Comprehensive Board Review in Hematology and Medical Oncology


LIVE
A Comprehensive Board Review in Hematology and Medical Oncology Banner

  • Overview
  • Faculty
Add to Calendar A Comprehensive Board Review in Hematology and Medical Oncology 10/3/2022 7:30:00 AM 10/8/2022 5:30:00 PM America/Mexico_City Virtual false MM/DD/YYYY


Date & Location
Monday, October 3, 2022, 7:30 AM - Saturday, October 8, 2022, 5:30 PM, Virtual, Houston, TX

Target Audience
Specialties - General Oncology

Credits
AMA PRA Category 1 Credits™ (51.25 hours), Non-Physician Attendance (51.25 hours), ABIM MOC Part 2 (51.25 hours)

Overview
The course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies.


Objectives
At the conclusion of this activity, learners will be able to:

  1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty.
  2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
  3. Demonstrate proficiency of knowledge in hematology and medical oncology.
  4. Incorporate recent advances in management of hematologic and oncologic patients.
  5. Define molecular determinants of cancer risk and apply this knowledge in practice.

Registration

A Virtual Live Streaming Course

More information and registration details will follow on a later date.


Accreditation
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 51.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 50.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf. 

 




Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 




The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
John M Stewart, MD/PhD
Professor
UT MDACC
CE Reviewer
Nothing to disclose
Sharon H. Giordano, Md, FASCO
Dr.
University of Texas MD Anderson Cancer Center
Co-Director
Nothing to disclose
Tapan Kadia, MD
Dr.
MD Anderson Cancer Center
Co-Director
Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Pfizer Inc.|Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Ascentage|Grant or research support-Cellenkos|Grant or research support-AstraZeneca US|Grant or research support-Astellas Scientific and Medical Affairs, Inc.|Paid consultant-AbbVie Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Jazz Pharmaceuticals|Paid consultant-Jazz Pharmaceuticals|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Agios Pharmaceuticals Inc.|Paid consultant-Pfizer Inc.
Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine
Co-Director
Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Biogen Inc.|Other: conduct of clinical trials-Millennium Pharmaceuticals, Inc., The Takeda Oncology Company|Other: Conduct of clinical trials-Celgene Corporation|Other: Conduct of clinical trials-Incyte Corporation|Other: conduct of clinical trials-inovio (Relationship has ended)|Other: conduct of clinical trials-Aveo
Nishin Bhadkamkar, MD
Associate Professor
MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Felisha Estelle, BBA
CE Activity Planner
MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Alessandra Ferrajoli, MD
Professor of Medicine
M.D. Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Other Planning Committee Member
Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Blueprint Medicines Corporation (Relationship has ended)|Consulting Fee-Daiichi Sankyo, Inc. (Relationship has ended)|Consulting Fee-GlaxoSmithKline (Relationship has ended)

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2020 The University of Texas MD Anderson Cancer Center
See us on Facebook See us on Twitter See us on Linked In See us on Instagram